Home » Topics » BioWorld Science

BioWorld Science
RSS

New selective estrogen receptor degradation inducers patented by Zeno Royalties & Milestones

Feb. 15, 2019

The Helleday Foundation describes ADP-sugar pyrophosphatase inhibitors

Feb. 15, 2019

IL-13Ralpha2 as a novel marker and potential therapeutic target for malignant melanoma

Feb. 15, 2019

New PAI-1 inhibitors presented by Eastern Michigan University and the University of Michigan

Feb. 15, 2019

ChemoCentryx synthesizes new PD-1/PD-L1 interaction inhibitors

Feb. 15, 2019

University of Utah, Stingray Therapeutics patent E-NPP 1 inhibitors/STING modulators

Feb. 15, 2019

MELK as a novel therapeutic target for neuroblastoma

Feb. 15, 2019

KA-11 demonstrates promising activity in preclinical models of epilepsy and pain

Feb. 15, 2019

Phase III studies of brexpiprazole in patients with bipolar I disorder do not meet primary endpoint

Feb. 15, 2019

Advaxis initiates phase I/II study of ADXS-503 in patients with NSCLC

Feb. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...